News

Winners of CPHI Excellence in Pharma Awards Announced

October 08, 2024

The winners of this year’s awards showcase achievements in pharma excellence.

CPHI Research Forecasts Growth for Biotech, Pharma Markets in 2025

October 08, 2024

European biotechs have had a strong year in 2024, causing those in the United States to increasingly look to them for innovation.

CPHI Milan 2024: Growth and Challenges in the Sterile Injectables Market

October 08, 2024

James Hamilton, president of Sharp Sterile, discussed innovation in products associated with sterile manufacturing and industry trends that are driving growth.

CMOs and Hybrid Companies Predicted to Hold 54% of Biologics Capacity in 2028, According to CPHI Annual Survey

October 08, 2024

According to the annual survey, four of the five biggest biologics capacity holders in 2028 will comprise CMOs, which are expected to have 45% of all CMO capacity in Asia.

Datwyler Launches NeoFlex Plungers at CPHI Milan 2024

October 08, 2024

The company has expanded its NeoFlex coated plungers with new sizes for large-volume auto-injectors and wearable devices.

Thermo Fisher Launching New CDMO, CRO Services at CPHI Milan

October 08, 2024

The introduction of Accelerator Drug Development follows expansions of sites in Cincinnati, Ohio, and Bend, Ore., earlier in 2024 to enable R&D, manufacturing, and testing.

CPHI Milan 2024: Flavonoids in Pharmaceuticals

October 08, 2024

Pharmaceutical Technology® Europe sat down with Álvaro Nocete Díaz, Pharma Division Manager at HTBA, about the benefits of flavonoids and their use in the pharmaceutical industry.

CPHI Milan 2024: Navigating CMC Challenges for GLP-1 and Oral Peptides

October 08, 2024

Andrew Lewis, PhD, Chief Scientific Officer, Quotient Sciences, discussed the CMC challenges with GLP-1 and oral peptides during CPHI Milan.

Cellevate Plans Pre-Launch of First Nanofiber Microcarriers for Viral Vector Manufacturing at CPHI Milan

October 07, 2024

The nanofiber microcarriers are the first of their kind for manufacturing viral vectors used in gene therapy production, according to Cellevate.

Enzene to Launch Continuous Manufacturing Technology at CPHI Milan 2024

October 07, 2024

The CDMO will be launching its EnzeneX 2.0 continuous manufacturing for biologics technology during CPHI Milan, which is being held Oct. 8–10, 2024 in Milan, Italy.